These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3467125)

  • 1. Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.
    Sehested M; Skovsgaard T; van Deurs B; Winther-Nielsen H
    J Natl Cancer Inst; 1987 Jan; 78(1):171-9. PubMed ID: 3467125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumor cells.
    Sehested M; Bindslev N; Demant EJ; Skovsgaard T; Jensen PB
    Biochem Pharmacol; 1989 Sep; 38(18):3017-27. PubMed ID: 2571333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic investigations on a Ehrlich ascites tumor, and four sublines resistant to daunomycin, adriamycin, vincristine and vinblastine.
    Hasholt L; Dan0 K
    Hereditas; 1974; 77(2):303-10. PubMed ID: 4141349
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
    Sehested M; Skovsgaard T; van Deurs B; Winther-Nielsen H
    Br J Cancer; 1987 Dec; 56(6):747-51. PubMed ID: 3435701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lectin staining patterns of plasma membranes of daunorubicin and vincristine resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(6):366-70. PubMed ID: 2453973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic free Ca2+ in daunorubicin and vincristine resistant Ehrlich ascites tumor cells. Drug accumulation is independent of intracellular Ca2+ changes.
    Bouchelouche P; Friche E; Sehested M; Jensen PB; Skovsgaard T
    Biochem Pharmacol; 1991 Jan; 41(2):243-53. PubMed ID: 1899193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells.
    Skovsgaard T
    Cancer Res; 1978 Dec; 38(12):4722-7. PubMed ID: 719649
    [No Abstract]   [Full Text] [Related]  

  • 8. The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells.
    Sehested M; Skovsgaard T; Roed H
    Biochem Pharmacol; 1988 Sep; 37(17):3305-10. PubMed ID: 3401258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of tumor cell resistance to 4'-deoxy-4'-iododoxorubicin developed in Ehrlich ascites cells in vivo.
    Friche E; Danks MK; Beck WT
    Cancer Res; 1992 Oct; 52(20):5701-6. PubMed ID: 1356619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells.
    Demant EJ; Sehested M; Jensen PB
    Biochim Biophys Acta; 1990 Nov; 1055(2):117-25. PubMed ID: 2242381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D; Eriksen J; Maare C; Friche E; Skovsgaard T
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analogues.
    Friche E; Jensen PB; Roed H; Skovsgaard T; Nissen NI
    Biochem Pharmacol; 1990 Jun; 39(11):1721-6. PubMed ID: 2344368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.
    Dano K
    Cancer Chemother Rep; 1972 Dec; 56(6):701-8. PubMed ID: 4660629
    [No Abstract]   [Full Text] [Related]  

  • 14. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
    Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW
    Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
    Seeber S; Loth H; Crooke ST
    J Cancer Res Clin Oncol; 1980; 98(2):109-18. PubMed ID: 6938517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.
    Dano K
    Biochim Biophys Acta; 1973 Oct; 323(3):466-83. PubMed ID: 4796512
    [No Abstract]   [Full Text] [Related]  

  • 19. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
    Friche E; Jensen PB; Sehested M; Demant EJ; Nissen NN
    Cancer Commun; 1990; 2(9):297-303. PubMed ID: 1976341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.